News

HPV 16 E7-specific T-cell responses were elicited in all four subjects in the study’s third cohort following administration of 500mcg of HspE7 and 1,000mcg of Poly-ICLC, a potent

Under the terms of the agreement, VGX will provide multiple batches of a Cystic fibrosis transmembrane conductance regulator (CFTR) product to support clinical studies planned to run through

This Phase I study is in support of the development of NVC-422 as a product candidate to treat or prevent catheter associated urinary tract infections. In this trial,

Ranbaxy and Merck will work together to develop clinically validated antibacterial and anti-fungal drug candidates. Ranbaxy will carry-out drug discovery and clinical development through Phase IIa clinical trials,

The approval was based on positive results from a Phase III study comparing topotecan hard capsules plus best supportive care (BSC ) to BSC alone in patients with

All patients enrolled in the Sonic II Registry are scheduled for follow-up at 30 days, six months, and one year following the OmniWave procedure. The first patient was

The primary objective of this open-label, single-arm trial is to determine if preoperative administration of NOV-002 in combination with eight cycles of chemotherapy (four of doxorubicin and cyclophosphamide

AGS-004 is a product of the company’s Arcelis technology, a personalized, RNA-loaded dendritic cell-based immunotherapy that is perfectly matched to each patient’s unique HIV viral burden. The target

Forest will record a one-time charge of $44.1 million which is composed of a one-time payment to Daiichi Sankyo of $26.6 million related to the termination and $17.5